Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiacheng Bi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Immunology and Cell Biology|February 17, 2017
Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in miceHongling Zhang, Jiacheng Bi, Huqiang Yi, et al.
Cellular & Molecular Immunology|January 19, 2022
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapyXiaohu Zheng, Yaqi Wu, Jiacheng Bi, et al.
Science Advances|September 15, 2021
TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunityJiacheng Bi, Chen Cheng, Chaoyue Zheng, et al.
Frontiers in Immunology|September 17, 2021
Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, PanobinostatLukman O Afolabi, Jiacheng Bi, Xuguang Li, et al.
Journal for Immunotherapy of Cancer|March 24, 2026
Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinomaYan Zhu, Maoxuan Liu, Xiaokai Fan, et al.
Cell Reports. Medicine|June 16, 2026
TIGIT-targeted IL-12 fusion protein engages NK and CD8<sup>+</sup> T cells for potent tumor immunotherapyMaoxing Tang, Yingying Huang, Jiacheng Bi, et al.
Nature Immunology|June 20, 2018
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunityQing Zhang, Jiacheng Bi, Xiaodong Zheng, et al.
Frontiers in Immunology|September 7, 2021
Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer <i>Salmonella</i>Shuxin Yang, Wenjuan Zhao, Muchun Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2025
Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinomaQingmei Zhang, Wing-Lim Chan, Sin-Yee Fung, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Immunology and Cell Biology|February 17, 2017
Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in miceHongling Zhang, Jiacheng Bi, Huqiang Yi, et al.
Cellular & Molecular Immunology|January 19, 2022
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapyXiaohu Zheng, Yaqi Wu, Jiacheng Bi, et al.
Science Advances|September 15, 2021
TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunityJiacheng Bi, Chen Cheng, Chaoyue Zheng, et al.
Frontiers in Immunology|September 17, 2021
Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, PanobinostatLukman O Afolabi, Jiacheng Bi, Xuguang Li, et al.
Journal for Immunotherapy of Cancer|March 24, 2026
Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinomaYan Zhu, Maoxuan Liu, Xiaokai Fan, et al.
Cell Reports. Medicine|June 16, 2026
TIGIT-targeted IL-12 fusion protein engages NK and CD8<sup>+</sup> T cells for potent tumor immunotherapyMaoxing Tang, Yingying Huang, Jiacheng Bi, et al.
Nature Immunology|June 20, 2018
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunityQing Zhang, Jiacheng Bi, Xiaodong Zheng, et al.
Frontiers in Immunology|September 7, 2021
Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer <i>Salmonella</i>Shuxin Yang, Wenjuan Zhao, Muchun Zhu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2025
Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinomaQingmei Zhang, Wing-Lim Chan, Sin-Yee Fung, et al.
Pageof 4